Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN vs CASPOFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANIDULAFUNGIN vs CASPOFUNGIN: Safety Overview

Metric ANIDULAFUNGIN CASPOFUNGIN
Total FAERS Reports 701 3,814
Deaths Reported 325 1,419
Death Rate 46.4% 37.2%
Hospitalizations 287 1,638
Average Patient Age 53.3 yrs 47.5 yrs
% Female Patients 40.0% 42.8%
FDA Approval Date Feb 17, 2006 Dec 30, 2016
Manufacturer Roerig Sandoz Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued